Research from the GTA

Is there another way to think about Alpha Synuclein?

Alberto Espay and Anthony Lang think through Parkinson’s Disease and Alpha Synuclein and come up with some compelling hypotheses

Is this really the cause?

Is there a better way to do Parkinson’s Research?

With a 0 for 18 track record in phase 3 clinical trials for a disease modifying treatment, is it time to wonder if there are other ways to tackling Parkinson’s that would be effective? Alberto Espay and Anthony Lang have a view.

Systems (its connected) Biology vs Reductionist (bits and parts) Thinking